[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2019-2023 Global Prothrombin Time (PT) Market: US, Europe, Japan--Volume and Sales Segmentation Forecasts, Competitive Landscape, Current Methods and Instrumentation, Opportunities for Suppliers

July 2019 | 200 pages | ID: 27580350859EN
Venture Planning Group

US$ 3,450.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and PT testing specifically, will become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the PT testing closer to the patient, creating additional opportunities and challenges for suppliers.

This report presents a detailed analysis of the PT testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice, as well as 5-year test volume forecasts by country and market segment.

The report examines market applications of chromogenic substrates, monoclonal antibodies, immunoassays, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 200 pages and 8 tables
I. INTRODUCTION

II. WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Introduction
B. Prothrombin Time: Clinical Significance and Current Laboratory Procedures
C. Instrumentation Review
Introduction
Benk Hemolab
Benk TRT Thrombotimer
Bio/Data MCA
Bio/Data MCA
Bio/Data PAP-4C D/4D/4C
Cardiovascular Diagnostics COAG
Diagnostica Stago STA Compact
Diagnostica Stago STA-R
Diagnostica Stago Star 4/8
Helena Laboratories Cascade
Helena Laboratories Cascade M
Helena Laboratories PACKS-4
Helena THOR
Instrumentation Laboratory ACL 100 and 1000 series
Instrumentation Laboratory ACL6000
Instrumentation Laboratory ACL7000
Instrumentation Laboratory ACL9000
Instrumentation Laboratory Electra 1000C
Instrumentation Laboratory Electra 1400C
Instrumentation Laboratory Electra 1600/C
Instrumentation Laboratory Electra 1800C
Instrumentation Laboratory Futura
ITC Hemochron 8000
Roche Diagnostics CoaguChek
Siemens BCS
Siemens BCT
Siemens BF II/Fibrintimer Series
Sysmex CA-50
Sysmex CA-500
Sysmex CA-1500
Sysmex CA-5000/CA-1000
Sysmex CA-6000
Sysmex CA-7000
Teco Coatron II/Jr./AccuStasis 5000
Trinity Biotech Amax CS190
Trinity Biotech Amax CS400
Trinity Biotech Coag-A-Mate Max
Trinity Biotech KC 40, 4A, 1A Series
Trinity Biotech MDA
Trinity Biotech Coag-A-Mate MTX
Trinity Biotech Coag-A-Mate RA4
Trinity Biotech Coag-A-Mate XC/Plus
Trinity Biotech Coag-A-Mate XM
D. Major in Vitro Diagnostic Technologies and Their Potential Applications
  1. Chromogenic Substrates
  2. Monoclonal and Polyclonal Antibodies
  3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
      Overview
      ELISA
      EMIT
      Dot Immunobinding Assays
      Capillary Immunoassays
      Enzyme Amplification
      Electrochemical Immunoassay
    d. Fluorescent Immunoassays
      Fluorescence Polarization
      Time-Resolved Pulse Fluorescence
      Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
  4. Microcomputers
  5. Automation
  6. Robotics
  7. DNA Probes
    a. Overview
    b. Amplification Methods
      PCR
      Ligase Chain Reaction
      Branched DNA
      Q-Beta Replicase
      NASBA
      SDA
      3 SR
      HPA
      Two-Tiered System
      LAT
  8. Artificial Intelligence
  9. Dry Chemistry
  10. Biosensors

III. FRANCE: TEST VOLUME FORECASTS BY MARKET SEGMENT

IV. GERMANY: TEST VOLUME FORECASTS BY MARKET SEGMENT

V. ITALY: TEST VOLUME FORECASTS BY MARKET SEGMENT

VI. JAPAN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VII. SPAIN: TEST VOLUME FORECASTS BY MARKET SEGMENT

VIII. UK: TEST VOLUME FORECASTS BY MARKET SEGMENT

IX. USA: TEST VOLUME FORECASTS BY MARKET SEGMENT

X. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

XI. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types Of Distributors
  7. Market Segmentation

XII. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

XIII. COMPETITIVE ASSESSMENTS

Abbott
ADI/American Diagnostica
Alere/Biosite/Inveness
Axis-Shield
Beckman Coulter
Becton Dickinson
Bio/Data Corporation
Chrono-Log
Corgenix Medical
Diagnostica Stago/Trinity Biotech
Grifols
Helena Laboratories
HYPEN BioMed
Instrumentation Laboratory
ITC
Roche
Siemens
Sienco
Sysmex
Thermo Fischer
ZyCare/Alere

LIST OF TABLES

Major Companies Developing or Marketing PT Tests
France
PT Test Volume Forecasts by Market Segment
Germany
PT Test Volume Forecasts by Market Segment
Italy
PT Test Volume Forecasts by Market Segment
Japan
PT Test Volume Forecasts by Market Segment
Spain
PT Test Volume Forecasts by Market Segment
U.K.
PT Test Volume Forecasts by Market Segment
U.S.A.
PT Test Volume Forecasts by Market Segment


More Publications